» Articles » PMID: 8473288

Binding of Lipoprotein Lipase to Heparin. Identification of Five Critical Residues in Two Distinct Segments of the Amino-terminal Domain

Overview
Journal J Biol Chem
Specialty Biochemistry
Date 1993 Apr 25
PMID 8473288
Citations 37
Authors
Affiliations
Soon will be listed here.
Abstract

Binding to heparan sulfate governs many aspects of the physiological action and regulation of the lipolytic enzyme, lipoprotein lipase (LPL). In an attempt to identify the structural determinants which mediate this interaction, basic residues in three segments of the primary sequence of human LPL (residues 147-151, 279-282, and 292-304) were replaced with alanine, either singly or in various combinations, and variant proteins were subjected to affinity chromatography on heparin-Superose. Five basic residues in two distinct segments of the primary sequence were critical determinants of the high affinity for heparin manifested by the active enzyme (R279, K280, R282, K296, R297). By contrast, no such evidence could be detected for basic residues in the first cluster (K147, K148) or for other basic residues in the third cluster (K292, R294, K304), while the evidence for K300 was unresolved. The conformation of this heparin-binding domain can be inferred by reference to the three-dimensional structure of the homologous enzyme, pancreatic lipase (Winkler, F. K., D'Arcy, A., and Hunziker, W. (1990) Nature 343, 771-774). Affinity of the active enzyme for heparin could not be reduced below a threshold, suggesting that other heparin-binding determinants exist elsewhere in the molecule, as supported by recently published evidence (Davis, R. C., Wong, H., Nikazy, J., Wang, K., Han, Q., and Schotz, M. C. (1992) J. Biol. Chem. 267, 21499-21504).

Citing Articles

Macromolecular Interactions of Lipoprotein Lipase (LPL).

Wheless A, Gunn K, Neher S Subcell Biochem. 2024; 104:139-179.

PMID: 38963487 DOI: 10.1007/978-3-031-58843-3_8.


Identification and Characterization of Two Novel Compounds: Heterozygous Variants of in Two Pedigrees With Type I Hyperlipoproteinemia.

Wang S, Cheng Y, Shi Y, Zhao W, Gao L, Fang L Front Endocrinol (Lausanne). 2022; 13:874608.

PMID: 35923617 PMC: 9339609. DOI: 10.3389/fendo.2022.874608.


Syndecan-1 Mediates Sorting of Soluble Lipoprotein Lipase with Sphingomyelin-Rich Membrane in the Golgi Apparatus.

Sundberg E, Deng Y, Burd C Dev Cell. 2019; 51(3):387-398.e4.

PMID: 31543446 PMC: 6832887. DOI: 10.1016/j.devcel.2019.08.014.


GPIHBP1 and Lipoprotein Lipase, Partners in Plasma Triglyceride Metabolism.

Young S, Fong L, Beigneux A, Allan C, He C, Jiang H Cell Metab. 2019; 30(1):51-65.

PMID: 31269429 PMC: 6662658. DOI: 10.1016/j.cmet.2019.05.023.


Lipoprotein lipase is active as a monomer.

Beigneux A, Allan C, Sandoval N, Cho G, Heizer P, Jung R Proc Natl Acad Sci U S A. 2019; 116(13):6319-6328.

PMID: 30850549 PMC: 6442593. DOI: 10.1073/pnas.1900983116.